Both in vitro and in vivo results confirmed that RUNX1-mediated ECM remodeling promoted pathologically increased infiltration of M2 macrophages and decreased the number of cytotoxic T cells, which finally formed an immunosuppressive microenvironment in GBM. This evidence concerns the gene RUNX1 and glioblastoma.